152 related articles for article (PubMed ID: 11843554)
1. Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens.
Bibbo M; Klump WJ; DeCecco J; Kovatich AJ
Acta Cytol; 2002; 46(1):25-9. PubMed ID: 11843554
[TBL] [Abstract][Full Text] [Related]
2. P16INK4A as an adjunct test in liquid-based cytology.
Bibbo M; DeCecco J; Kovatich AJ
Anal Quant Cytol Histol; 2003 Feb; 25(1):8-11. PubMed ID: 12630076
[TBL] [Abstract][Full Text] [Related]
3. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E expression and early cervical neoplasia in ThinPrep specimens. A feasibility study.
Weaver EJ; Kovatich AJ; Bibbo M
Acta Cytol; 2000; 44(3):301-4. PubMed ID: 10833982
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
[TBL] [Abstract][Full Text] [Related]
6. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
[TBL] [Abstract][Full Text] [Related]
7. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.
Negri G; Egarter-Vigl E; Kasal A; Romano F; Haitel A; Mian C
Am J Surg Pathol; 2003 Feb; 27(2):187-93. PubMed ID: 12548164
[TBL] [Abstract][Full Text] [Related]
8. The utility of p16INK4a and Ki-67 staining on cell blocks prepared from residual thin-layer cervicovaginal material.
Akpolat I; Smith DA; Ramzy I; Chirala M; Mody DR
Cancer; 2004 Jun; 102(3):142-9. PubMed ID: 15211472
[TBL] [Abstract][Full Text] [Related]
9. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
10. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results.
Meyer JL; Hanlon DW; Andersen BT; Rasmussen OF; Bisgaard K
Cancer; 2007 Apr; 111(2):83-92. PubMed ID: 17334990
[TBL] [Abstract][Full Text] [Related]
11. Morphologic characteristics of p16INK4a-positive cells in cervical cytology samples.
Trunk MJ; Dallenbach-Hellweg G; Ridder R; Petry KU; Ikenberg H; Schneider V; von Knebel Doeberitz M
Acta Cytol; 2004; 48(6):771-82. PubMed ID: 15581161
[TBL] [Abstract][Full Text] [Related]
12. [Association between high risk HPV viral load, p16ink4a expression and intra-epithelial cervical lesions].
Eleutério Junior J; Giraldo PC; Cavalcante DI; Gonçalves AK; Eleutério RM
Rev Assoc Med Bras (1992); 2007; 53(6):530-4. PubMed ID: 18157369
[TBL] [Abstract][Full Text] [Related]
13. Utility of p16(ink4a) immunocytochemistry in liquid-based cytology specimens from women treated for high-grade squamous intraepithelial lesions.
Carydis VB; Walker T; Wing A; Colgan TJ
Acta Cytol; 2007; 51(4):517-22. PubMed ID: 17718114
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.
Hong IS; Marshalleck J; Williams RH; Gaiter TE; Mielzynska-Lohnas I; Kim K
Acta Cytol; 2002; 46(5):828-34. PubMed ID: 12365215
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples.
Wentzensen N; Bergeron C; Cas F; Eschenbach D; Vinokurova S; von Knebel Doeberitz M
Cancer; 2005 Dec; 105(6):461-7. PubMed ID: 16116604
[TBL] [Abstract][Full Text] [Related]
16. A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.
Pan Q; Belinson JL; Li L; Pretorius RG; Qiao YL; Zhang WH; Zhang X; Wu LY; Rong SD; Sun YT
Acta Cytol; 2003; 47(1):45-50. PubMed ID: 12585030
[TBL] [Abstract][Full Text] [Related]
17. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix.
Nieh S; Chen SF; Chu TY; Lai HC; Fu E
Gynecol Oncol; 2003 Oct; 91(1):201-8. PubMed ID: 14529682
[TBL] [Abstract][Full Text] [Related]
18. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.
Rinas AC; Mittman BW; Le LV; Hartmann K; Cayless J; Singh HK
Acta Cytol; 2006; 50(1):55-62. PubMed ID: 16514841
[TBL] [Abstract][Full Text] [Related]
19. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
20. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
